Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • orphan drug

    Tag: orphan drug

    You Searched For "orphan drug"
    AstraZeneca gets orphan drug designation for pancreatic cancer drug Lynparza

    AstraZeneca gets orphan drug designation for pancreatic cancer drug Lynparza

    Medical Dialogues Bureau24 March 2020 11:30 AM IST
    UK: AstraZeneca has announced that Lynparza (olaparib) has been granted orphan drug designation (ODD) in Japan for the maintenance treatment of...
    TG Therapeutics gets USFDA Orphan Drug Designation for follicular lymphoma drug Umbralisib

    TG Therapeutics gets USFDA Orphan Drug Designation for follicular lymphoma drug Umbralisib

    Medical Dialogues Bureau9 March 2020 10:45 AM IST
    New York - TG Therapeutics, Inc.today announced that the U.S. Food and Drug Administration (FDA) granted orphan drug designation to umbralisib,...
    SPARC neonatal seizures drug Phenobarbital gets Orphan Drug Designation from USFDA

    SPARC neonatal seizures drug Phenobarbital gets Orphan Drug Designation from USFDA

    Farhat Nasim5 Oct 2019 12:00 PM IST
    Orphan Drug Designation will grant seven years of US market exclusivity upon approval of Phenobarbital for the treatment of patients with neonatal...
    Sun Pharma Research Arm- SPARC gets USFDA orphan drug designation for novel kinase inhibitor

    Sun Pharma Research Arm- SPARC gets USFDA orphan drug designation for novel kinase inhibitor

    Medical Dialogues Bureau9 July 2019 12:49 PM IST
    Mumbai: Sun Pharma Advanced Research Company (SPARC) on Monday said the US health regulator has given orphan drug designation to its novel kinase...

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok